NASDAQ:CSBR - Nasdaq - US15870P3073 - Common Stock - Currency: USD
Overall CSBR gets a fundamental rating of 4 out of 10. We evaluated CSBR against 56 industry peers in the Life Sciences Tools & Services industry. There are concerns on the financial health of CSBR while its profitability can be described as average. CSBR has a correct valuation and a medium growth rate.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 20.98% | ||
ROE | 117.52% | ||
ROIC | 49.38% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 11.48% | ||
PM (TTM) | 10.97% | ||
GM | 51.58% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.02 | ||
Debt/FCF | N/A | ||
Altman-Z | 1.64 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 0.99 | ||
Quick Ratio | 0.99 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 14.64 | ||
Fwd PE | 34.58 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | 12.45 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
NASDAQ:CSBR (7/16/2025, 1:02:20 PM)
7.76
-0.04 (-0.51%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 14.64 | ||
Fwd PE | 34.58 | ||
P/S | 1.83 | ||
P/FCF | N/A | ||
P/OCF | N/A | ||
P/B | 19.62 | ||
P/tB | 20.9 | ||
EV/EBITDA | 12.45 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 20.98% | ||
ROE | 117.52% | ||
ROCE | 62.51% | ||
ROIC | 49.38% | ||
ROICexc | 70.31% | ||
ROICexgc | 73.57% | ||
OM | 11.48% | ||
PM (TTM) | 10.97% | ||
GM | 51.58% | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.02 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | 0.01 | ||
Cap/Depr | 1.47% | ||
Cap/Sales | 0.04% | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 0.99 | ||
Quick Ratio | 0.99 | ||
Altman-Z | 1.64 |